Associate Director, Investor Relations

Posted Yesterday
Be an Early Applicant
7 Locations
In-Office or Remote
185K-220K Annually
Expert/Leader
Healthtech • Biotech • Pharmaceutical
The Role
Develop and execute investor relations strategy for a clinical-stage biotechnology company. Build relationships with institutional investors, shareholders, and analysts; communicate clinical, regulatory, and corporate milestones; prepare executives for investor engagements; manage investor communications, market insights, analyst relationships, IR materials, and external resources while ensuring securities-regulation compliance.
Summary Generated by Built In

Company: 

At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye. Our novel scientific approach targets upstream C1q to block the classical complement inflammatory cascade before it starts, and its therapeutic candidates are designed to provide meaningful benefits across multiple autoimmune, neurodegenerative and ophthalmic diseases. With proof-of concept data in Guillain-Barré syndrome, Huntington’s disease and geographic atrophy, we are rigorously advancing our mid-to late-stage clinical trials to bring new potential treatments to patients as quickly as possible. At Annexon, you’ll be part of a team committed to making an impact together.   

For more information on Annexon and our pipeline, check out our site Annexon Biosciences & Annexon Pipeline. We trade on Nasdaq under the ticker symbol ANNX and are headquartered in Brisbane, CA. 

We're seeking exceptional talent from all backgrounds to fuel our growth. At Annexon, we're building a diverse, equitable, and inclusive workplace. We value unique perspectives and unconventional paths. If you're the best candidate for the job, even if you don't perfectly fit the traditional mold, we encourage you to apply. Learn more about our commitment to diversity, equity, inclusion, and our company culture! 

Position:

The Associate Director of Investor Relations at Annexon Biosciences will play a crucial role in developing and executing the investor relations strategy while strengthening relationships with the investment community. Reporting to the Chief Financial Officer, this individual will serve as a primary contact for investors and analysts, collaborating closely with the executive team to effectively communicate Annexon’s strategic goals and long-term value proposition.

Responsibilities:

  • Develop and execute a comprehensive investor relations strategy in alignment with corporate objectives, in partnership with the executive leadership team.
  • Build and maintain strong relationships with institutional investors, shareholders, sell-side analysts, and other investment community members.
  • Serve as the primary contact for investor and analyst inquiries, ensuring timely and consistent communication.
  • Refine corporate messaging and investment thesis to clearly convey the company’s strategy and milestones to investors.
  • Translate scientific, clinical, and regulatory information into compelling messages for the investment community.
  • Lead investor communications around clinical and corporate milestones, including data readouts and regulatory interactions.
  • Prepare executive leadership for investor meetings, earnings calls, and other external engagements.
  • Develop an active investor engagement calendar, including conferences, roadshows, and one-on-one meetings.
  • Monitor market trends, shareholder composition, and provide feedback regarding investor perceptions to senior leadership.
  • Manage relationships with sell-side analysts and ensure compliance with securities regulations in partnership with Legal and Finance.
  • Oversee the investor relations section of the corporate website and key IR materials.
  • Manage external investor relations resources as appropriate.

Education, Experience, and Skills: 

Required: 

  • Bachelor’s degree required; degrees in life sciences, finance, business, or a related discipline preferred. Advanced degree is a plus.
  • 10+ years of relevant experience in biotechnology, pharmaceutical, investor relations, or related fields, with direct experience at a public biotech or pharmaceutical company preferred.
  • Strong understanding of clinical development and ability to communicate complex data to healthcare investors.
  • Established relationships with the biotechnology investment community, including institutional investors and analysts, preferred.
  • Success in developing investor targeting strategies and building relationships with the investment community.
  • Exceptional written and verbal communication skills for developing investor-facing materials.
  • Strong executive presence and interpersonal skills for effective representation with external stakeholders.
  • Collaborative, with the ability to work across various functions and levels of the organization.
  • Excellent organizational skills, able to manage multiple priorities in a fast-paced environment.
  • Proactive, strategic, and able to operate independently while supporting senior leadership.

Salary Range: $185,000 - $220,000

Location: Annexon Biosciences is located in Brisbane, California and preference is given to candidates in the San Francisco Bay Area. 

Benefits: 

  • A stimulating and rewarding workplace includes flexible work schedules, remote opportunities and the ability to achieve a work-life balance.
  • Shuttle service from BART, CalTrain and the Ferry.
  • Annexon offers a competitive base salary and equity participation, employee stock purchase plan, as well as a comprehensive health benefit package that includes medical, dental, vision, 401(k), flexible spending plans, and other benefits. 

Annexon Biosciences is an Equal Opportunity Employer, and we prohibit discrimination or harassment of any kind.  We are committed to fostering an environment where ALL people are welcome and supported. We cultivate a culture of inclusion for all employees that respects their individual strengths, views, and experiences. We believe that our differences enable us to be a better team – one that makes better decisions, drives innovation, and delivers better business results. Creativity and innovation flourish in an environment of openness, inclusion, and mutual respect. 

Skills Required

  • Bachelor's degree
  • 10+ years of relevant experience in biotechnology, pharmaceutical, investor relations, or related fields
  • Strong understanding of clinical development and ability to communicate complex data to healthcare investors
  • Success developing investor targeting strategies and building investment-community relationships
  • Exceptional written and verbal communication skills
  • Strong executive presence and interpersonal skills
  • Ability to collaborate across functions and organizational levels
  • Excellent organizational skills and ability to manage multiple priorities
  • Proactive, strategic, and able to operate independently while supporting senior leadership
  • Degree in life sciences, finance, business, or related discipline
  • Advanced degree
  • Direct experience at a public biotechnology or pharmaceutical company
  • Established relationships with the biotechnology investment community, including institutional investors and analysts
Am I A Good Fit?
beta
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company
HQ: South San Francisco, CA
81 Employees
Year Founded: 2011

What We Do

Annexon (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye. The company’s pipeline is based on its platform technology addressing a broad spectrum of well-researched classical complement-mediated autoimmune and neurodegenerative diseases triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is advancing a portfolio of innovative product candidates designed to block the activity of C1q and the entire classical complement pathway: ANX005 (intravenous administration), ANX007 (intravitreal administration), and ANX009 (subcutaneous administration). Annexon is deploying a disciplined, biomarker-driven strategy designed to improve the probability of technical success of its portfolio. For more information, visit www.annexonbio.com.

Similar Jobs

UL Solutions Logo UL Solutions

Field Engineer

Automotive • Professional Services • Software • Consulting • Energy • Chemical • Renewable Energy
Remote or Hybrid
Québec, QC, CAN
15000 Employees
65K-78K Annually

Square Logo Square

Head of Social - Square

eCommerce • Fintech • Hardware • Payments • Software • Financial Services
Remote or Hybrid
8 Locations
12000 Employees
153K-245K Annually

GitLab Logo GitLab

Senior Software Engineer

Cloud • Security • Software • Cybersecurity • Automation
Easy Apply
Remote
2 Locations
2500 Employees
139K-235K Annually

GitLab Logo GitLab

Staff Software Engineer

Cloud • Security • Software • Cybersecurity • Automation
Easy Apply
Remote
4 Locations
2500 Employees
153K-259K Annually

Similar Companies Hiring

Granted Thumbnail
Artificial Intelligence • Healthtech • Insurance • Mobile • Financial Services
New York, New York
23 Employees
OneImaging Thumbnail
Healthtech
Miami, FL
62 Employees
Vitalize Thumbnail
Artificial Intelligence • Healthtech • Software
US
50 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account